Prevalence of human leptospirosis in the Americas: a systematic review and meta-analysis
Rev Panam Salud Publica
; 47, ago. 2023
Article
in English
| PAHO-IRIS
| ID: phr-57876
Responsible library:
US1.1
ABSTRACT
[ABSTRACT]. Objective. To describe the prevalence of leptospirosis in the Americas. Methods. A systematic review and meta-analysis, in the period 1930 to 2017, performed on a search of six platforms PubMed, Web of Science, Scopus, Lilacs, Embase, and Cochrane. Results. The search found 77 publications of which 53 (68%) were from the period 2000–2017. Of the 77, 62 studies were included in the analysis, from North America (11, 17%), Central America (9, 14%), and South America (42, 67%), and 22 studies were from urban areas. Leptospirosis prevalence in the 62 studies ana- lyzed corresponded to 28% (95% CI [23, 32]). Countries with higher prevalence were United States of America (41%), Colombia (29%), and Brazil (21%). The most frequent serovars found were Icterohaemorrhagiae (43 of 77 publications, 55%), Canicola (35, 45%), Pomona (28, 36%), and Grippotyphosa (26, 33%). Conclusions. There is variability of Leptospira species and serovars with heterogenous distribution through- out the Americas, with high prevalence in some countries, highlighting the need for action to control the disease.
Full text:
Available
Collection:
Databases of international organizations
Health context:
SDG3 - Health and Well-Being
Health problem:
Target 3.3: End transmission of communicable diseases
Database:
PAHO-IRIS
Main subject:
Americas
/
Prevalence
/
Meta-Analysis
/
Serogroup
/
Leptospirosis
Type of study:
Prevalence study
/
Risk factors
/
Systematic review
Language:
English
Year:
2023
Document type:
Article